(Q39032923)

8 September 2017

title

CXCL12 secreted from glioma stem cells regulates their proliferation (English)

1 reference

8 September 2017

Youji Uemae

1

1 reference

8 September 2017

Eiichi Ishikawa

2

1 reference

8 September 2017

Satoru Osuka

3

1 reference

8 September 2017

Masahide Matsuda

4

1 reference

8 September 2017

Noriaki Sakamoto

5

1 reference

8 September 2017

Shingo Takano

6

1 reference

8 September 2017

Kei Nakai

7

1 reference

8 September 2017

Tetsuya Yamamoto

8

1 reference

8 September 2017

Akira Matsumura

9

1 reference

8 September 2017

language of work or name

1 reference

19 January 2014

1 reference

Journal of Neuro-Oncology

8 September 2017

published in

1 reference

8 September 2017

volume

117

1 reference

8 September 2017

issue

1

1 reference

8 September 2017

page(s)

43-51

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-014-1364-y

8 September 2017

exact match

0 references

cites work

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

Intratumoral injection of IL-2-activated NK cells enhances the antitumor effect of intradermally injected paraformaldehyde-fixed tumor vaccine in a rat intracranial brain tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

Clinical trial of autologous formalin-fixed tumor vaccine for glioblastoma multiforme patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

Phase I/IIa trial of autologous formalin-fixed tumor vaccine concomitant with fractionated radiotherapy for newly diagnosed glioblastoma. Clinical article.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

Transdifferentiation of glioblastoma cells into vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

Molecular therapeutic targets for glioma angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

Angiogenesis inhibition for glioblastoma at the edge: beyond AVAGlio and RTOG 0825.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

CXCR4 mediates the proliferation of glioblastoma progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

CXCL12 (SDF-1)/CXCR4 pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

An infernal trio: the chemokine CXCL12 and its receptors CXCR4 and CXCR7 in tumor biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

CXCR4 expression mediates glioma cell invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

A perivascular niche for brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1α function through distinct receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1364-Y

CXCL12 mediates apoptosis resistance in rat C6 glioma cells.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24442483

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24442483

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pilot study of anti-angiogenic vaccine using fixed whole endothelium in patients with progressive malignancy after failure of conventional therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24442483

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-014-1364-Y

1 reference

8 September 2017

1 reference